Licensed Information Sample Clauses

Licensed Information. Any Proprietary Information of or used by Glycyx which is or may be subject to an exclusive licence to CKD hereunder, shall not be disclosed by Glycyx to any Third Party for use in the Territory except for purposes not inconsistent with such exclusive license and only pursuant to confidentiality and non-use restrictions at least as restrictive as those provided herein.
Licensed Information. Seller uses the Licensed Information in connection not only with the Auction Businesses, but also in connection with one or more of its Retained Businesses. As provided in Section 2.1(5) above, Seller is granting to Buyer and its Affiliates the Information License. Buyer understands and agrees that Seller shall continue to be the owner of and will continue to use the Licensed Information subject to the restrictions contained in the Non-Competition Agreement.
Licensed Information. Upon request of Rani, Celltrion will promptly cooperate to provide to Rani all Licensed Information reasonably requested and will provide Rani with letters of authorization (i.e., a right of reference) to any requested Regulatory Filings or Regulatory Approvals related to Drug (e.g., IND, biologics license application or new drug application) that are reasonably necessary for Rani’s development, manufacture or commercialization of Product.
Licensed Information. In return for the royalties and other payments described in Section 4, Licensors grant to Licensee a royalty-bearing, exclusive license under the Licensed Information in the Licensed Field and Licensed Territory to make, have made, use, have used, sell, offer to sell, have offered to sell, import, have imported, develop, have developed, research, have researched, commercialize and have commercialized Licensed Products. For clarity, Licensee shall be permitted to seek the right to export and have exported Licensed Products under this Agreement.
Licensed Information. The Special Conditions of the Agreement shall determine the Licensed Information by the Subscriber, specifying each and all of the Information Products included, and setting the date from which each and all of the said Information Products will be made available to the Subscriber.
Licensed Information. Any Proprietary Information of or used by Biorex -------------------- which is or may be subject to an exclusive licence to Glycyx hereunder, shall not be disclosed by Biorex to any Third Party for use in the Territory except for purposes not inconsistent with such exclusive license and only pursuant to confidentiality and non-use restrictions at least as restrictive as those provided herein.
Licensed Information. 13 11.4 Terms of this Agreement................................................ 13 Article 12.
Licensed Information. Effective as of the Closing, Company hereby grants and agrees to grant to Buyer and its subsidiaries a perpetual, worldwide, paid-up, non-exclusive license to use the Business Information (a) related to or used in the Business or (b) located at the Facility (the "Licensed Information"), and such license may be assigned, extended, sublicensed or otherwise transferred, in whole or in part, by Buyer to any other party. Company will furnish Licensed Information located at the Facility to Buyer on the Closing Date, and at the request of Company, Buyer shall make copies of such Licensed Information for Company following the Closing. Company will furnish Licensed Information that is not located at the Facility on the Closing Date to Buyer as soon as possible after the Closing Date, but in no event later than sixty (60) days after the Closing Date, and pending such delivery, Company shall provide access to such Licensed Information in accordance with Section 7.11.(b). Notwithstanding the foregoing, as to any books, records, contracts, other documents or data of Company relating to the Purchased Assets or the Business that includes information not relating to the Purchased Assets or the Business (other than in a nominal or inconsequential manner) ("Other Information"), Company shall not be obligated to make Other Information available, but Company shall (i) to the extent practicable, redact (physically, electronically or otherwise) the Other Information or (ii) use commercially reasonable efforts to prepare and present the information Buyer requests in any other reasonable manner such that Other Information is not made available to Buyer.
Licensed Information. Any Proprietary Information of or used by -------------------- Biorex which are or may be subject to an exclusive license to Salix hereunder shall not be disclosed by Biorex to any third party for use in the Territory except for purposes not inconsistent with such exclusive license and only pursuant to confidentiality and non-use restrictions at least as restrictive as those provided herein.

Related to Licensed Information

  • Excluded Information For purposes of this Agreement, the term “confidential and proprietary information” shall not include (i) information already known or independently developed by the recipient without the use of any confidential and proprietary information, or (ii) information known to the public through no wrongful act of the recipient.

  • Product Information EPIZYME recognizes that by reason of, inter alia, EISAI’s status as an exclusive licensee in the EISAI Territory under this Agreement, EISAI has an interest in EPIZYME’s retention in confidence of certain information of EPIZYME. Accordingly, until the end of all Royalty Term(s) in the EISAI Territory, EPIZYME shall keep confidential, and not publish or otherwise disclose, and not use for any purpose other than to fulfill EPIZYME’s obligations, or exercise EPIZYME’s rights, hereunder any EPIZYME Know-How Controlled by EPIZYME or EPIZYME Collaboration Know-How, in each case that are primarily applicable to EZH2 or EZH2 Compounds (the “Product Information”), except to the extent (a) the Product Information is in the public domain through no fault of EPIZYME, (b) such disclosure or use is expressly permitted under Section 9.3, or (c) such disclosure or use is otherwise expressly permitted by the terms and conditions of this Agreement. For purposes of Section 9.3, each Party shall be deemed to be both the Disclosing Party and the Receiving Party with respect to Product Information. For clarification, the disclosure by EPIZYME to EISAI of Product Information shall not cause such Product Information to cease to be subject to the provisions of this Section 9.2 with respect to the use and disclosure of such Confidential Information by EPIZYME. In the event this Agreement is terminated pursuant to Article 12, this Section 9.2 shall have no continuing force or effect, but the Product Information, to the extent disclosed by EPIZYME to EISAI hereunder, shall continue to be Confidential Information of EPIZYME, subject to the terms of Sections 9.1 and 9.3 for purposes of the surviving provisions of this Agreement. Each Party shall be responsible for compliance by its Affiliates, and its and its Affiliates’ respective officers, directors, employees and agents, with the provisions of Section 9.1 and this Section 9.2.

  • Background Information The Adviser has entered into an Investment Adviser's Agreement with the Fund ("Investment Adviser's Agreement"). Pursuant to the Investment Adviser's Agreement, the Adviser has agreed to render investment advisory and certain other management services to all of the funds of the Fund, and the Fund has agreed to employ the Adviser to render such services and to pay to the Adviser certain fees therefore. The Investment Adviser's Agreement recognizes that the Adviser may enter into agreements with other investment advisers who will serve as fund managers to the funds.

  • Technical Information The Employer agrees to provide to the Union such information that is available relating to employees in the bargaining unit, as may be required by the Union for collective bargaining purposes.

  • Requested Information with reasonable promptness, such other data and information relating to the business, operations, affairs, financial condition, assets or properties of the Company or any of its Subsidiaries or relating to the ability of the Company to perform its obligations hereunder and under the Notes as from time to time may be reasonably requested by any such holder of Notes.